"The blockbuster weight loss drug sold as Ozempic and Wegovy will soon go generic in countries that are home to 40 percent of the world’s population, significantly lowering the price of a costly medicine that had been largely unaffordable to nearly all but the wealthiest people."

https://www.nytimes.com/2026/03/19/health/ozempic-wegovy-generic-india-china-canada.html

#healthcare #PrescriptionDrugs #generics #obesity #DrugPrices #CostsOfCare #PhRMA #patents

Ozempic Is About to Go Generic in India, China and Canada

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.

The New York Times